Skip to main content
See every side of every news story
Published • loading... • Updated

Breast Cancer, Oncologist De Angelis: "Multigenic Test in Leas, Now Ensure Access to All Patients"

Summary by canaledieci.it
(Adnkronos) - Multigenic tests represent a concrete application of precision medicine in breast cancer. Today, thanks to these tools, we can identify patients who can safely omit chemotherapy in their treatment path. In Italy in 2021 was established a fund for the reimbursement of these tests and, just a few [...]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

8 Articles

(Adnkronos) - Multigenic tests represent a concrete application of precision medicine in breast cancer. Today, thanks to these tools, we can identify patients who can safely omit chemotherapy in their treatment path. In Italy in 2021 was established a fund for the reimbursement of these tests and, just a few [...]

Giornale RadioGiornale Radio
+4 Reposted by 4 other sources

"Multigenic tests represent a concrete application of precision medicine in breast cancer. Today, thanks to these tools, we can identify patients who can safely omit chemotherapy in their treatment path. In Italy in 2021 a fund was established for the reimbursement of these tests and, just a few weeks ago, was announced their introduction in the Lea. It is a further step towards a greater possibility of access to fundamental tools for patients w…

“Multigenic tests represent a concrete application of precision medicine in breast cancer. Today, thanks to these tools, we can identify patients who can safely omit chemotherapy in their treatment path. In Italy, in 2021, a fund was established for the reimbursement of these tests and, just a few weeks ago, their introduction into the LEAs was announced. This is a further step towards greater access to essential tools for patients with breast c…

·Bologna, Italy
Read Full Article

The multigenic tests represent a concrete application of precision medicine in breast cancer. Today, thanks to these tools, we can identify patients who can safely omit chemotherapy in their treatment path. In Italy, in 2021, a fund was established for the reimbursement of these tests and, just a few weeks ago, [...] L'articolo Tumoro sine, oncologist De Angelis is multigenic test in the Lea, now guaranteeing access to all of them comes from Rec…

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Rec News | Lontani dal mainstream broke the news on Tuesday, November 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal